Waterford, CT, United States of America

Michael S Kellogg


Average Co-Inventor Count = 1.2

ph-index = 5

Forward Citations = 61(Granted Patents)


Location History:

  • Waterford, CT (US) (1981 - 1987)
  • Barington Hills, IL (US) (1992)

Company Filing History:


Years Active: 1981-1992

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Innovations of Michael S. Kellogg in Beta-Lactam Compounds

Introduction

Michael S. Kellogg is a distinguished inventor located in Waterford, CT, United States. With a remarkable portfolio of 12 patents, Kellogg has made significant contributions to the field of pharmacology, particularly in the development of novel beta-lactam compounds.

Latest Patents

His latest patents include groundbreaking work on beta-lactam elastase inhibitors. These novel compounds demonstrate potent elastase inhibition activity and are characterized by complex structural formulae. Specifically, the compounds are distinguished by parameters such as X and Y being --S-- or --CH₂--, with at least one of these being --S--. Alternatively, X may be --SO-- or --SO₂-- and Y may be --CH₂--. The versatility of R¹ and R³ as hydrogen, tri(lower alkyl)silyl, and various alkyl or phenyl groups highlights their utility as anti-inflammatory agents. These compounds hold promise in treating conditions such as adult respiratory distress syndrome and rheumatoid arthritis.

Career Highlights

Michael S. Kellogg works at Pfizer Corporation, a leading global pharmaceutical company known for its innovative research and drug development. His research focuses on enhancing the effectiveness of beta-lactam antibiotics against beta-lactamase producing bacteria through his patented 6-beta-substituted penicillanic acid compounds. Additionally, he has developed processes for converting specific penicillanic acid derivatives to their corresponding congeners.

Collaborations

Throughout his career, Kellogg has collaborated with various professionals in the field, including notable coworkers Vytautas J. Jasys and Ernest S. Hamanaka. These partnerships have fostered a culture of innovation, leading to advancements in pharmaceutical research and drug efficacy.

Conclusion

Michael S. Kellogg continues to be a pivotal figure in pharmaceutical innovation. His contributions, especially in the realm of beta-lactam compounds, highlight the impact of dedicated inventors on medical science. With ongoing research and collaboration, Kellogg's work promises to further enhance therapeutic strategies in combating serious health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…